Pharmacoeconomic analysis of prostaglandin and prostamide therapy for patients with glaucoma or ocular hypertension
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2415
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Pharmacoeconomic analysis of prostaglandin and prostamide therapy for patients with glaucoma or ocular hypertension ; volume:7 ; number:1 ; day:27 ; month:9 ; year:2007 ; pages:1-8 ; date:12.2007
BMC ophthalmology ; 7, Heft 1 (27.9.2007), 1-8, 12.2007
- Urheber
-
Frenkel, Ronald EP
- Beteiligte Personen und Organisationen
-
Frenkel, Max
Toler, Allison
SpringerLink (Online service)
- DOI
-
10.1186/1471-2415-7-16
- URN
-
urn:nbn:de:1111-201604144310
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Frenkel, Ronald EP
- Frenkel, Max
- Toler, Allison
- SpringerLink (Online service)
Ähnliche Objekte (12)
Corneal hysteresis in patients with glaucoma-like optic discs, ocular hypertension and glaucoma
The Effect of Prostaglandin Analogs on Central Corneal Thickness of Patients with Glaucoma or Ocular Hypertension: A Systematic Review
Airborne particulate matter (PM2.5) triggers ocular hypertension and glaucoma through pyroptosis
Travoprost Intracameral Implant Demonstrates Superior IOP Lowering Versus Topical Prostaglandin Analog Monotherapy in Patients with Open-Angle Glaucoma or Ocular Hypertension
Incidence of new coding for dry eye and ocular infection in open-angle glaucoma and ocular hypertension patients treated with prostaglandin analogs: Retrospective analysis of three medical/pharmacy claims databases
Prostaglandin-based rAAV-mediated glaucoma gene therapy in Brown Norway rats
Latanoprostene Bunod Ophthalmic Solution 0.024%: A Review in Open-Angle Glaucoma and Ocular Hypertension
Preservative-free tafluprost 0.0015% in the treatment of patients with glaucoma and ocular hypertension
Comparative analysis of tear cytokines in patients with glaucoma, ocular hypertension, and healthy controls
Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: The VISIONARY Study
Proteomic and Cytokine Profiling in Plasma from Patients with Normal-Tension Glaucoma and Ocular Hypertension
Persistence on prostaglandin ocular hypotensive therapy: an assessment using medication possession and days covered on therapy
Corneal hysteresis in patients with glaucoma-like optic discs, ocular hypertension and glaucoma
The Effect of Prostaglandin Analogs on Central Corneal Thickness of Patients with Glaucoma or Ocular Hypertension: A Systematic Review
Airborne particulate matter (PM2.5) triggers ocular hypertension and glaucoma through pyroptosis
Travoprost Intracameral Implant Demonstrates Superior IOP Lowering Versus Topical Prostaglandin Analog Monotherapy in Patients with Open-Angle Glaucoma or Ocular Hypertension
Incidence of new coding for dry eye and ocular infection in open-angle glaucoma and ocular hypertension patients treated with prostaglandin analogs: Retrospective analysis of three medical/pharmacy claims databases
Prostaglandin-based rAAV-mediated glaucoma gene therapy in Brown Norway rats
Latanoprostene Bunod Ophthalmic Solution 0.024%: A Review in Open-Angle Glaucoma and Ocular Hypertension
Preservative-free tafluprost 0.0015% in the treatment of patients with glaucoma and ocular hypertension
Comparative analysis of tear cytokines in patients with glaucoma, ocular hypertension, and healthy controls
Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: The VISIONARY Study
Proteomic and Cytokine Profiling in Plasma from Patients with Normal-Tension Glaucoma and Ocular Hypertension
Persistence on prostaglandin ocular hypotensive therapy: an assessment using medication possession and days covered on therapy
Corneal hysteresis in patients with glaucoma-like optic discs, ocular hypertension and glaucoma
The Effect of Prostaglandin Analogs on Central Corneal Thickness of Patients with Glaucoma or Ocular Hypertension: A Systematic Review
Airborne particulate matter (PM2.5) triggers ocular hypertension and glaucoma through pyroptosis
Travoprost Intracameral Implant Demonstrates Superior IOP Lowering Versus Topical Prostaglandin Analog Monotherapy in Patients with Open-Angle Glaucoma or Ocular Hypertension
Incidence of new coding for dry eye and ocular infection in open-angle glaucoma and ocular hypertension patients treated with prostaglandin analogs: Retrospective analysis of three medical/pharmacy claims databases
Prostaglandin-based rAAV-mediated glaucoma gene therapy in Brown Norway rats
Latanoprostene Bunod Ophthalmic Solution 0.024%: A Review in Open-Angle Glaucoma and Ocular Hypertension
Preservative-free tafluprost 0.0015% in the treatment of patients with glaucoma and ocular hypertension
Comparative analysis of tear cytokines in patients with glaucoma, ocular hypertension, and healthy controls
Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: The VISIONARY Study
Proteomic and Cytokine Profiling in Plasma from Patients with Normal-Tension Glaucoma and Ocular Hypertension